🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Gene-modified lymphocytes may stimulate the immune system in dif...
Status
Terminated
Location
Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office
Start Date
2008-06
Trial ID
NCT00704938
Gastrointestinal (GI) cancers account for the most common cancers. Despite ...
Status
Completed
Location
University hospital of Besançon
Start Date
2009-11
Trial ID
NCT02845999
RATIONALE: An infusion of a patient's lymphocytes that have been treated in...
Status
Terminated
Location
Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support
Start Date
2005-07
Trial ID
NCT00138229
Treatments Being Tested
This is a multi-institutional Phase I/II study of an allogeneic KIR-HLA mis...
Status
Recruiting
Location
Mark Juckett, MD
Start Date
2026-05-08
Trial ID
NCT07591649
Treatments Being Tested
This phase II trial studies how well autologous tumor infiltrating lymphocy...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2018-04-27
Trial ID
NCT03449108
This randomized phase II trial studies how well giving pembrolizumab with s...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2015-08-07
Trial ID
NCT02500576
Phase I Study of NT-175, an autologous T cell therapy product genetically e...
Status
Recruiting
Location
Research Site
Start Date
2023-07-12
Trial ID
NCT05877599
Treatments Being Tested
New York Esophageal Squamous Cell Carcinoma 1 (NY-ESO-1) is a cancer-testis...
Status
Recruiting
Location
TCRCure Biopharma Ltd.
Start Date
2023-06-01
Trial ID
NCT05881525
Treatments Being Tested
The study purpose is to learn about the safety and tolerability of IMA101 a...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2017-06-30
Trial ID
NCT02876510
This phase I/II trial studies the side effects of laboratory-treated T cell...
Status
Terminated
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2012-12-06
Trial ID
NCT01640301